News and Updates

Updated 4/2/2021. Check this page frequently for the latest information regarding the Prescription Drug Plan formulary, changes to coverage policies, and other relevant news for plan members.

Drug Recalls

The University of Michigan's Prescription Drug Plan will keep members up-to-date with important information regarding drug recalls. Members potentially impacted by a drug recall related to a medication's safety or efficacy may receive a letter from Magellan Rx with information about the recall, and what they should do for next steps. For more information on recent drug recalls, visit Magellan Rx's website or visit the FDA’s website.

COVID-19 Vaccine Updates

The COVID-19 vaccine is a covered pharmacy-administered vaccine. U-M’s benefits plans cover approved vaccinations under both your pharmacy through the U-M Prescription Drug Plan and through your U-M health plan. Approved vaccines require no co-pay on your part. When receiving your vaccine at a pharmacy, provide either your medical or drug plan ID card. To avoid confusion, don't use both cards at the same time. Learn about COVID-19 vaccine eligibility and availability.

Pharmacy Benefits and Advisory Committee (PBAC) Updates

The Pharmacy Benefits and Advisory Committee (PBAC), consisting of clinical subject matter experts within Michigan Medicine and the University of Michigan, meets regularly to review and approve changes to the Prescription Drug Plan formulary. Check the formulary for up to date formulary status. Formulary status is subject to change. Here are the latest updates.

April 2021

New Drug Products Added to Formulary

Effective April 1, 2021, the following changes will be made to the Prescription Drug Plan’s formulary. Review the formulary.

  • Tepotinib (Tepmetko) – Tier 2, Specialty, PA, QL, Split-Fill
  • Umbralisib (Ukoniq) – Tier 2, Specialty, PA, QL, Split-Fill
  • Tivozanib (Fotivda) – Tier 3, Specialty, PA, QL

New Generics Added to Formulary

  • Zafemy Contraceptive Patch (Generic for Xulane)
  • Loteprednol 0.5% Gel (Generic for Lotemax)
  • Brinzolamide 1% (Generic for Azopt)
  • Hydrocodone ER (Generic for Hysingla ER)

March 2021

New Drug Products Added to Formulary

Effective March 1, 2021, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

  • Vericiguat (Verquvo) – Tier 3, PA, QL
  • Tirbanibulin (Klisyri) – Tier 3, QL
  • Voclosporin (Lupkynis) – Tier 3, LDD, PA, QL
  • Solifenacin (Vesicare) Suspension – Tier 2, QL
  • Tofacitinib (Xeljanz) Solution – Tier 2, Specialty, PA, QL

New Generics Added to Formulary

  • Lubiprostone (Generic for Amitiza)
  • Zolmitriptan 2.5 mg, 5 mg nasal spray (Generic for Zomig)
  • Nitazoxanide 500 mg (Generic for Alinia)